The company said total company sales in Q3 2024 were $33.6 billion, down from $34.0 billion in the same period last year. Identical sales excluding fuel rose 2.3%. Earnings per share were $0.84, and adjusted EPS was $0.98.

1. 01

   The company said total company sales in Q3 2024 were $33.6 billion, down from $34.0 billion in the same period last year. Identical sales excluding fuel rose 2.3%. Earnings per share were $0.84, and adjusted EPS was $0.98.

2. 02

   Kroger said it completed the sale of its Kroger Specialty Pharmacy business on October 4, 2024 for $464 million. It said total sales in Q3 were reduced by about $340 million compared with the same period last year, and annualized sales will be about $3 billion lower going forward. It said the sale had no material effect on operating profit.

3. 03

   The company said it narrowed its full-year 2024 guidance. Adjusted FIFO operating profit guidance moved from $4.6 to $4.8 billion to $4.6 to $4.7 billion, and adjusted EPS guidance moved from $4.30 to $4.50 to $4.35 to $4.45.

4. 04

   Kroger said its net total debt to adjusted EBITDA ratio was 1.21, compared with 1.40 a year ago. It said it has paused its share repurchase program to prioritize de-leveraging following the proposed merger with Albertsons.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.